1460 related articles for article (PubMed ID: 17353286)
21. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells.
Carnaud C; Lee D; Donnars O; Park SH; Beavis A; Koezuka Y; Bendelac A
J Immunol; 1999 Nov; 163(9):4647-50. PubMed ID: 10528160
[TBL] [Abstract][Full Text] [Related]
22. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.
Cardell SL
Clin Exp Immunol; 2006 Feb; 143(2):194-202. PubMed ID: 16412042
[TBL] [Abstract][Full Text] [Related]
23. Decreased frequency and proliferative response of invariant Valpha24Vbeta11 natural killer T (iNKT) cells in healthy elderly.
Peralbo E; DelaRosa O; Gayoso I; Pita ML; Tarazona R; Solana R
Biogerontology; 2006; 7(5-6):483-92. PubMed ID: 16953330
[TBL] [Abstract][Full Text] [Related]
24. Spontaneous tolerance involving natural killer T cells after hepatic grafting in mice.
Morita M; Fujino M; Li XK; Kimura H; Nakayama T; Taniguchi M; Sugioka A
Transpl Immunol; 2007 Nov; 18(2):142-5. PubMed ID: 18005859
[TBL] [Abstract][Full Text] [Related]
25. Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice.
Yoshimoto T; Min B; Sugimoto T; Hayashi N; Ishikawa Y; Sasaki Y; Hata H; Takeda K; Okumura K; Van Kaer L; Paul WE; Nakanishi K
J Exp Med; 2003 Apr; 197(8):997-1005. PubMed ID: 12695491
[TBL] [Abstract][Full Text] [Related]
26. Increased infiltration of CD1d and natural killer T cells in periodontal disease tissues.
Amanuma R; Nakajima T; Yoshie H; Yamazaki K
J Periodontal Res; 2006 Feb; 41(1):73-9. PubMed ID: 16409258
[TBL] [Abstract][Full Text] [Related]
27. Genetic background influences natural killer cell activation during bacterial peritonitis in mice, and is interleukin 12 and interleukin 18 independent.
Scott MJ; Hoth JJ; Gardner SA; Peyton JC; Cheadle WG
Cytokine; 2004 Nov; 28(3):124-36. PubMed ID: 15473954
[TBL] [Abstract][Full Text] [Related]
28. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
Sharif S; Arreaza GA; Zucker P; Mi QS; Sondhi J; Naidenko OV; Kronenberg M; Koezuka Y; Delovitch TL; Gombert JM; Leite-De-Moraes M; Gouarin C; Zhu R; Hameg A; Nakayama T; Taniguchi M; Lepault F; Lehuen A; Bach JF; Herbelin A
Nat Med; 2001 Sep; 7(9):1057-62. PubMed ID: 11533711
[TBL] [Abstract][Full Text] [Related]
29. A role for natural killer T cells and CD1d molecules in counteracting suppression of hematopoiesis in mice induced by infection with murine cytomegalovirus.
Broxmeyer HE; Dent A; Cooper S; Hangoc G; Wang ZY; Du W; Gervay-Haque J; Sriram V; Renukaradhya GJ; Brutkiewicz RR
Exp Hematol; 2007 Apr; 35(4 Suppl 1):87-93. PubMed ID: 17379092
[TBL] [Abstract][Full Text] [Related]
30. Invariant NKT cells preferentially modulate the function of CD8 alpha+ dendritic cell subset in inducing type 1 immunity against infection.
Joyee AG; Uzonna J; Yang X
J Immunol; 2010 Feb; 184(4):2095-106. PubMed ID: 20089704
[TBL] [Abstract][Full Text] [Related]
31. Role of invariant NK T lymphocytes in immune responses to CpG oligodeoxynucleotides.
Paget C; Bialecki E; Fontaine J; Vendeville C; Mallevaey T; Faveeuw C; Trottein F
J Immunol; 2009 Feb; 182(4):1846-53. PubMed ID: 19201836
[TBL] [Abstract][Full Text] [Related]
32. CD1d-restricted glycolipid antigens: presentation principles, recognition logic and functional consequences.
Florence WC; Bhat RK; Joyce S
Expert Rev Mol Med; 2008 Jul; 10():e20. PubMed ID: 18601810
[TBL] [Abstract][Full Text] [Related]
33. Does the developmental status of Valpha14i NKT cells play a role in disease?
Matsuda JL; Gapin L
Int Rev Immunol; 2007; 26(1-2):5-29. PubMed ID: 17454262
[TBL] [Abstract][Full Text] [Related]
34. Invariant natural killer T cells and immunotherapy of cancer.
Molling JW; Moreno M; van der Vliet HJ; van den Eertwegh AJ; Scheper RJ; von Blomberg BM; Bontkes HJ
Clin Immunol; 2008 Nov; 129(2):182-94. PubMed ID: 18783990
[TBL] [Abstract][Full Text] [Related]
35. The immunoregulatory role of CD1d-restricted natural killer T cells in disease.
van der Vliet HJ; Molling JW; von Blomberg BM; Nishi N; Kölgen W; van den Eertwegh AJ; Pinedo HM; Giaccone G; Scheper RJ
Clin Immunol; 2004 Jul; 112(1):8-23. PubMed ID: 15207777
[TBL] [Abstract][Full Text] [Related]
36. Methods for detection, isolation and culture of mouse and human invariant NKT cells.
Watarai H; Nakagawa R; Omori-Miyake M; Dashtsoodol N; Taniguchi M
Nat Protoc; 2008; 3(1):70-8. PubMed ID: 18193023
[TBL] [Abstract][Full Text] [Related]
37. Immunoregulation of autoimmunity by natural killer T cells.
Linsen L; Somers V; Stinissen P
Hum Immunol; 2005 Dec; 66(12):1193-202. PubMed ID: 16690406
[TBL] [Abstract][Full Text] [Related]
38. Invariant NKT cells and tolerance.
Nowak M; Stein-Streilein J
Int Rev Immunol; 2007; 26(1-2):95-119. PubMed ID: 17454266
[TBL] [Abstract][Full Text] [Related]
39. Ligand-dependent inhibition of CD1d-restricted NKT cell development in mice transgenic for the activating receptor Ly49D.
Voyle RB; Beermann F; Lees RK; Schümann J; Zimmer J; Held W; MacDonald HR
J Exp Med; 2003 Apr; 197(7):919-25. PubMed ID: 12682111
[TBL] [Abstract][Full Text] [Related]
40. Reduced CD4+ subset and Th1 bias of the human iNKT cells in Type 1 diabetes mellitus.
Kis J; Engelmann P; Farkas K; Richman G; Eck S; Lolley J; Jalahej H; Borowiec M; Kent SC; Treszl A; Orban T
J Leukoc Biol; 2007 Mar; 81(3):654-62. PubMed ID: 17151140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
